 NEW HAVEN, Conn., Nov. 05, 2020 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. BTI or Company Nasdaq: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, November 12, 2020 at 8:30 AM Eastern Time to discuss its third quarter 2020 operating and financial results. 